Polymerase Chain Reaction News and Research

RSS

Polymerase chain reaction (PCR) is a revolutionary laboratory technique that enables the replication of a specific DNA sequence. Using PCR, millions of copies of a target DNA can be easily synthesized within a short period of time.

Incidence of arterial and venous thromboembolism and death in COVID-19 patients

Researchers estimated the incidence of arterial or venous thrombosis in patients with coronavirus disease 2019.

19 May 2022

Prevalence of long COVID-19 after Omicron infection

A recent article posted to the medRxiv* preprint server analyzed the long coronavirus disease (COVID) linked with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant.

18 May 2022

Study explores neurologic complications in pediatric COVID-19 cases

Researchers evaluated neurologic complications in pediatric cases of COVID-19.

18 May 2022

Case report: human breast milk from vaccinated woman clears persistent SARS-CoV-2 infection

A new study published in the journal Viruses aimed to report the effects of plasma infusion and then breastmilk ingestion as a therapy for persistent SARS-CoV-2 infection in a patient with a common variable immunodeficiency (CVID) phenotype.

18 May 2022

The efficacy of CoronaVac against SARS-CoV-2 in cancer patients

In a recent study published in the Journal of Medical Virology, researchers analyzed the efficacy of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in preventing SARS-CoV-2 infection among cancer patients.

18 May 2022

Camelid IFNs could play important role in combating emerging zoonotic pathogens

In a recent study published in the Developmental & Comparative Immunology journal, the discovery of a novel form of mammalian interferon-Beta (IFN-β) with four cysteine residues from the dromedary camel and the five remaining members of the mammalian suborder Tylopoda is described.

17 May 2022

Scientists explore triggers associated with transplacental transmission of SARS-CoV-2

A new study examines the risk of fetal SARS-CoV-2 infection following infection of a pregnant mother with the virus.

17 May 2022

Mice live longer with nasal gene therapy

In a recent study published in the Proceedings of the National Academy of Sciences journal, researchers assessed the efficiency of a novel intranasal and injectable therapy in improving life expectancy.

17 May 2022

Factors impacting anti-SARS-CoV-2 antibodies in healthcare personnel

In a recent study posted to the medRxiv* preprint server, researchers assessed variables that influence anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody titers in medical professionals.

16 May 2022

Triple vaccination found to confer immune protection against SARS-CoV-2 Omicron BA.2 sublineage

Researchers assessed the immune responses induced by two doses or three doses of the BNT162b2 (BNT) or the CoronaVac (CorV) vaccine against SARS-CoV-2 Omicron BA.2 sublineage among public servants working for the government of Hong Kong.

16 May 2022

Study shows dengue virus can lower sperm production in men

A new study supports the notion that the dengue virus can be sexually transmissible for a short period after acute dengue illness and that it can also cause alterations in sperm production.

16 May 2022

Study reveals serum proteomic signatures of long COVID patients

In a recent study posted to the bioRxiv*preprint server, researchers evaluated the serum proteomic signatures of long coronavirus disease (COVID) patients.

13 May 2022

Dogs can detect SARS-CoV-2 from an individual's sweat

In a recent study published in the Open Forum Infectious Diseases (OFID) Journal, researchers reported that severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) could be detected by canine olfaction.

12 May 2022

Phase 1 trial of COVID-19 PTXCOVID19-B vaccine

A new study demonstrated that the SARS-CoV-2 PTXCOVID19-B vaccine was a promising SARS-CoV-2 vaccine option.

12 May 2022

Study finds recent influenza vaccination is associated with an appreciable reduction in the risk of SARS-CoV-2 infection and COVID-19 severity

The current study was performed in Qatar, including over 30,000 healthcare workers vaccinated against influenza during the period between September 17, 2020, and December 31, 2020, when the annual flu shots are usually given.

12 May 2022

COVID-19 booster vaccination strategy found to be highly cost-effective in Australia

Researchers evaluated the cost-effectiveness of Australia’s COVID-19 booster vaccination strategy.

12 May 2022

Research looks at potential of pantethine against SARS-CoV-2

In a recent study posted to the Research Square preprint server, researchers assessed the antiviral activity of pantethine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

12 May 2022

Study estimates effectiveness of 2-dose and 3-dose mRNA vaccination against Omicron

In a recent study posted to the medRxiv* preprint server, researchers estimated the efficacy of two-dose and three-dose regimens of two messenger ribonucleic acid (mRNA) vaccines: Moderna’s mRNA-1273 and Pfizer-BioNTech’s BNT162b2 against coronavirus disease 2019 (COVID-19) caused due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant.

12 May 2022

COVID-19 and cerebral blood flow

In a recent study posted to the medRxiv* preprint server, researchers assessed the impact of coronavirus disease 2019 (COVID-19) on cerebral blood flow in infected patients.

10 May 2022

Growing long-COVID health care burden

In a recent study posted to the medRxiv* preprint server, researchers assessed the long coronavirus disease (COVID) health care burden in Ontario, Canada.

10 May 2022